When Does Semaglutide Wear Off — and What Happens When It Does?

Does semaglutide wear off during the week between injections?

Yes, to a degree, and it is worth understanding why. Semaglutide is a GLP-1 receptor agonist: it mimics a gut hormone that signals fullness to your brain and slows the rate at which your stomach empties. After a subcutaneous injection, drug levels peak within a day or two, then decline over the following days as the body metabolises them. Because the half-life sits at around seven days, concentrations do not plummet sharply, they taper. Most people on a stable maintenance dose barely notice this. For others, especially in earlier weeks of treatment or after a dose increase, the last day or two before injection day can feel meaningfully different: hunger edges back in, food feels less effortless to manage. You can read more about how and why semaglutide levels taper across the weekly cycle if you want a closer look at what is happening.

This matters when you are thinking about when to take your weekly semaglutide dose. Keeping injection day consistent helps your body settle into a predictable rhythm. Shifting it by a day here and there (the sort of thing that happens around holidays, or when a payday order arrives a day late) can make the end-of-week dip feel worse than it otherwise would. Once you land on a day that works, it is worth protecting it. Our overview of how semaglutide works as a medicine covers the pharmacology in more depth if you want the fuller picture.

The NHS medicines page for semaglutide confirms the once-weekly dosing schedule and notes that missed or delayed doses can affect how well the medicine works, guidance on what to do in that situation sits in the Patient Information Leaflet your prescriber provides.

Does Wegovy wear off over time with continuous use?

This is a different question from the weekly fluctuation, and the honest answer is: the evidence does not strongly support tolerance developing in the way people sometimes fear. In the STEP 1 trial, published in the New England Journal of Medicine, participants continued to lose weight across the full 68-week study period at the 2.4mg maintenance dose. There was no clear plateau caused by the drug becoming less active, plateaus that did appear tended to reflect the body reaching a new equilibrium with reduced calorie intake, which is normal and expected in any weight-loss process.

That said, some people do report that appetite suppression feels less intense after many months at the same dose. Whether that reflects genuine pharmacological change or the brain adapting to a new normal is not fully resolved. What is well-established is that moving to a higher dose, where clinically appropriate, tends to restore the effect. The MHRA-approved titration schedule exists precisely for this reason. Our page on whether Wegovy wears off over time looks at this question in more clinical detail. The short version: the effect is sustained with continued use; it is not permanent without it.

What happens when you stop semaglutide, does the effect reverse?

Largely, yes. This is one of the better-documented findings across GLP-1 research and it is worth being straightforward about it. When people discontinue semaglutide, appetite regulation returns towards its pre-treatment baseline, because the medicine was doing the regulatory work. The STEP 1 extension data showed that, on average, participants regained a substantial proportion of lost weight within a year of stopping. The weight does not all come back overnight, but the trajectory is real.

This does not mean treatment must continue indefinitely for everyone, that is a clinical conversation. NICE's recommendation for semaglutide (Wegovy) under TA875 includes a maximum duration of two years within specialist weight management services on the NHS; private prescribing is assessed individually. What it does mean is that stopping should be a planned decision made with your prescriber, not something that happens because a pen runs out and a reorder feels inconvenient. Our clinical team discusses this at every repeat review, the plan for what comes after treatment is part of the conversation from the start. You can read more about Wegovy's licensed use in the UK and the prescribing framework our pharmacy follows.

If you are considering what a longer-term treatment plan might look like for you, exploring your treatment options with a prescriber is the right starting point.

Does the wearing-off effect signal that something has gone wrong?

Almost never. Noticing more hunger on day six or seven of your weekly cycle is not a sign that treatment is failing, that your pen was faulty, or that you are on the wrong dose. It is the expected pharmacokinetic pattern of a weekly medicine reaching the bottom of its cycle. A question our prescribers hear most weeks is whether this means the dose needs increasing, and the answer depends on far more than one hungry afternoon. Whether appetite is generally well-controlled across most of the week, whether weight is moving in the right direction, and how your body has tolerated each dose step all factor into that decision.

One thing worth checking, if the end-of-week effect is pronounced, is storage: semaglutide pens need to be refrigerated, and a pen that has been left at room temperature for longer than the approved window may degrade. Our page on whether semaglutide goes off covers storage questions properly, including what to look for. If you are uncertain about anything you are experiencing, our aftercare team is available seven days a week, and the MHRA's Yellow Card scheme is the right channel for reporting any unexpected side effects formally.